Drug intelligence / Profile preview

FKC929

Development stage: Preclinical
Lead developer: ElpasBio
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraarticular

Overview

FKC929 is an investigational stem cell therapy being developed by Fosun Kairos, the innovation center of Fosun Kite, for the treatment of knee osteoarthritis. The program is currently in the preclinical or IND-enabling stage of development. As a cell-based intervention, FKC929 is designed to address the degenerative pathology of osteoarthritis, likely by promoting cartilage tissue repair and modulating the inflammatory microenvironment within the knee joint to alleviate pain and improve physical function.

Beyond the preview

Go deeper on FKC929.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FKC929.

Explore the full profile